Exisulind
Exisulind induces apoptosis through the activation of protein kinase G (PKG) . Exisulind exhibits antineoplastic activity in solid tumour and haematological cancer cell lines and is an inhibitor of tumour growth in rodent models of colon, prostate, bladder, mammary and lung cancer.
Product Specifications
CAS Number
59973-80-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
372.41
Molecular Formula
C20H17FO4S
Notes
Research use only, not for human use.
Receptor
——
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15164244 1 Vial
Lentiviral human CC2D1B shRNA (UAS) - Lentiviral human CC2D1B shRNA (UAS, RFP) (100)
Ask
View Details 
MBS1199147-01 0.02 mg (E-Coli)
Recombinant Salmonella paratyphi A Non-canonical purine NTP phosphatase (yjjX)
Ask
View Details MBS1199147-02 0.1 mg (E-Coli)
Recombinant Salmonella paratyphi A Non-canonical purine NTP phosphatase (yjjX)
Ask
View Details MBS1199147-03 0.02 mg (Yeast)
Recombinant Salmonella paratyphi A Non-canonical purine NTP phosphatase (yjjX)
Ask
View Details